ATXS
Price
$6.74
Change
+$0.23 (+3.53%)
Updated
Aug 28, 11:14 AM (EDT)
Capitalization
367.39M
76 days until earnings call
COGT
Price
$12.37
Change
+$0.14 (+1.14%)
Updated
Aug 27 closing price
Capitalization
1.71B
81 days until earnings call
Interact to see
Advertisement

ATXS vs COGT

Header iconATXS vs COGT Comparison
Open Charts ATXS vs COGTBanner chart's image
Astria Therapeutics
Price$6.74
Change+$0.23 (+3.53%)
Volume$500
Capitalization367.39M
Cogent Biosciences
Price$12.37
Change+$0.14 (+1.14%)
Volume$601.22K
Capitalization1.71B
ATXS vs COGT Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. COGT commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a StrongBuy and COGT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (ATXS: $6.51 vs. COGT: $12.37)
Brand notoriety: ATXS and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 56% vs. COGT: 20%
Market capitalization -- ATXS: $367.39M vs. COGT: $1.71B
ATXS [@Biotechnology] is valued at $367.39M. COGT’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while COGT’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 2 bearish.
  • COGT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than COGT.

Price Growth

ATXS (@Biotechnology) experienced а +3.17% price change this week, while COGT (@Biotechnology) price change was +4.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.71B) has a higher market cap than ATXS($367M). COGT YTD gains are higher at: 58.590 vs. ATXS (-27.181). ATXS has higher annual earnings (EBITDA): -131.42M vs. COGT (-299.34M). ATXS has more cash in the bank: 259M vs. COGT (238M). ATXS has less debt than COGT: ATXS (4.77M) vs COGT (60.7M). ATXS (0) and COGT (0) have equivalent revenues.
ATXSCOGTATXS / COGT
Capitalization367M1.71B21%
EBITDA-131.42M-299.34M44%
Gain YTD-27.18158.590-46%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M238M109%
Total Debt4.77M60.7M8%
FUNDAMENTALS RATINGS
ATXS vs COGT: Fundamental Ratings
ATXS
COGT
OUTLOOK RATING
1..100
7964
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
87
Overvalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5036
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATXS's Valuation (56) in the Biotechnology industry is in the same range as COGT (87) in the Miscellaneous industry. This means that ATXS’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (88) in the Miscellaneous industry is in the same range as ATXS (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to ATXS’s over the last 12 months.

ATXS's SMR Rating (97) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that ATXS’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (36) in the Miscellaneous industry is in the same range as ATXS (50) in the Biotechnology industry. This means that COGT’s stock grew similarly to ATXS’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as ATXS (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to ATXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCOGT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 22 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LLYVB100.00N/A
N/A
Liberty Media Corporation
NNMTF0.95N/A
N/A
Nine Entertainment Co. Holdings Ltd
CTNR5.00N/A
N/A
Central Natural Resources, Inc.
PHYTF11.81N/A
N/A
Pyrophyte Acquisition Corp.
SMAWF270.36-5.09
-1.85%
Siemens AG

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-2.40%
CRNX - ATXS
52%
Loosely correlated
-1.71%
XENE - ATXS
51%
Loosely correlated
+0.57%
NRIX - ATXS
51%
Loosely correlated
+0.21%
DNLI - ATXS
50%
Loosely correlated
+0.32%
COGT - ATXS
49%
Loosely correlated
+1.14%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+1.14%
SPHDF - COGT
63%
Loosely correlated
N/A
IDYA - COGT
50%
Loosely correlated
+0.56%
CGON - COGT
50%
Loosely correlated
-2.03%
ATXS - COGT
50%
Loosely correlated
-2.40%
XNCR - COGT
48%
Loosely correlated
+1.52%
More